Researchers have successfully used AI to design antibodies that bind to cancer proteins. The breakthrough could slash development time from months to weeks and eliminate animal testing. This represents a major shift in how pharmaceuticals are created.
Researchers have developed a modular mRNA platform that overcomes critical safety limitations in cancer immunotherapy. The TITUR system combines tumor-targeting nanoparticles with microRNA regulation for precise tumor killing.
Researchers have developed a revolutionary gene editing approach that overcomes critical limitations in studying cellular organization. The breakthrough enables precise analysis of biomolecular condensates without altering their delicate balance.
Breakthrough Gene Therapy Platform Overcomes Tumor Treatment Resistance A revolutionary nanoplatform utilizing CRISPR gene editing technology has demonstrated remarkable potential…
